Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.

被引：0
|
作者：
Goel, Vivek [1 ]
Malik, Manish [2 ]
Bhalla, A. K. [3 ]
机构：
[1] Apollo Multispecialty Hosp, Nephrol, Kolkata, India
[2] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
[3] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 9S期
关键词：
D O I：
10.1097/01.tp.0001065280.60236.aa
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
305.7
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Influence of CYP3A5 polymorphisms on 5-year tacrolimus pharmacokinetics and renal function in renal transplant recipients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S710 - S710
  • [42] ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT
    Alghamdi, A.
    Lazear, D.
    Varnell, C.
    Seay, S.
    Hooper, D.
    Darland, L.
    Mizuno, T.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S10 - S10
  • [43] MARGINAL ADVANTAGE OF KNOWING PATIENT'S CYP3A5 GENOTYPE FOR TACROLIMUS DOSING
    Asberg, Anders
    Midtvedt, Karsten
    Guilder, Mikevan
    Storset, Elisabet
    Bremer, Sara
    Bergan, Stein
    Jelliffe, Roger
    Hartmann, Anders
    Neely, Michael
    TRANSPLANT INTERNATIONAL, 2013, 26 : 198 - 198
  • [44] Clinical impact of reassessed tacrolimus starting dose according to CYP3A5 genotype in kidney transplant recipients
    Largeau, B.
    Barin-Le Guellec, C.
    Longuet, H.
    Lesne, P.
    Bouvarel, A.
    Preteseille, L.
    Halimi, J. M.
    Buchler, M.
    Gatault, P.
    Noble, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 38 - 38
  • [45] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Can Hu
    Wen-jun Yin
    Dai-yang Li
    Jun-jie Ding
    Ling-yun Zhou
    Jiang-lin Wang
    Rong-rong Ma
    Kun Liu
    Ge Zhou
    Xiao-cong Zuo
    European Journal of Clinical Pharmacology, 2018, 74 : 1437 - 1447
  • [46] Frequencies and Association of CYP3A5 Polymorphism With Tacrolimus Concentration Among Renal Transplant Recipients in Vietnam
    Xuan, Nguyen Thanh
    Hop, Vu Quang
    Kien, Truong Quy
    Toan, Pham Quoc
    Thang, Le Viet
    Binh, Ha Thanh
    Van Tran, Pham
    Minh, Hoang Thi
    Man, Pham Thi
    Cuong, Hoang Xuan
    Ben, Nguyen Huu
    Phuong, Nguyen Minh
    Linh, Nguyen Tung
    Linh, Nguyen Thuy
    Dung, Vu Dinh
    Quyen, Le Thi Bao
    Hang, Dinh Thi Thu
    Su, Hoang Xuan
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (08) : 2140 - 2146
  • [47] Value of CYP3A5 Genotyping on Determining Initial Dosages of Tacrolimus for Chinese Renal Transplant Recipients
    Zhang, J.
    Zhang, X.
    Liu, L.
    Tong, W.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3459 - 3464
  • [48] COMPARISON OF TACROLIMUS STARTING DOSES BASED ON CYP3A5 PHENOTYPE OR GENOTYPE IN KIDNEY TRANSPLANT RECIPIENTS.
    Largeau, B.
    Noble, J.
    Longuet, H.
    Halimi, J.
    Buchler, M.
    Gatault, P.
    Marquet, P.
    Barin-Le Guellec, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S102 - S103
  • [49] Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
    Campagne, Olivia
    Mager, Donald E.
    Brazeau, Daniel
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1184 - 1195
  • [50] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
12345